Sharleen Linette O'Reilly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sharleen Linette O'Reilly has a total of 565 co-authors. Here are the top co-authors by number of shared publications:
- Fionnuala M. McAuliffe
UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland
19 shared publications - James A. Dunbar
Greater Green Triangle University Department of Rural Health, Flinders and Deakin Universities, Warrnambool, Victoria, Australia
16 shared publications - Siew Lim
Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia
16 shared publications - Vincent Lawrence Versace
Deakin University
15 shared publications - Timothy Charles Skinner
School of Psychology and Institute for Health Transformation, Deakin University, Geelong, VIC 3220, Australia
11 shared publications - Helena Jane Teede
Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia
9 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Cambridge University Press (CUP) in Journal of Nutritional Science
- Vol. 15, e91
The effect of a combined milk protein hydrolysate and yeast β-glucan supplement on maternal immune, cardiometabolic and gastrointestinal health: the WellFed randomised controlled trial
The early postpartum period is a time of intense metabolic and physiological stress as maternal recovery from pregnancy impacts immune, cardiometabolic and gastrointestinal health. Studies considering the effect of nutrition on key maternal health parameters at this critical period are lacking. A combined supplement of bovine casein hydrolysate and yeast β-glucan has been shown to improve growth, intestinal health and inflammation in animal models, but studies in humans, including early postpartum lactating women, are lacking. In this 4-week randomised controlled trial, breastfeeding women ( n 58) at 4-weeks postpartum consumed a supplement containing either: 1) a combination of 250 mg casein hydrolysate (LFC16) and 250 mg yeast β-glucan (Wellmune®) or 2) a maltodextrin control. Gastrointestinal health was self-assessed using the Structured Assessment of Gastro-Intestinal Symptoms (SAGIS) tool. At baseline, mothers reported an issue with constipation (56.5%), difficulty with defaecation (58.7%), an urgency to defaecate (6.7%), or diarrhoea (6.7%). In response to intervention, cytokine expression in peripheral blood mononuclear cells (PBMCs) and cardiometabolic health were unchanged following supplementation. After 4-weeks the intervention improved constipation domain scores ( P = 0.049) and was almost twice as likely to improve SAGIS total domain score (80.0%) compared to control (45.5%, P = 0.011). This work highlights the residual effects of pregnancy on maternal gastrointestinal health parameters in the early postpartum period, and the potential of a combined casein hydrolysate and yeast β-glucan to improve gastrointestinal health, although limited findings on inflammation were observed. Further studies in larger sample sizes are warranted.
- 9 November 2026
- Published by Cambridge University Press (CUP) in Journal of Nutritional Science
- Vol. 15, e91
Open AccessThe effect of a combined milk protein hydrolysate and yeast β-glucan supplement on maternal immune, cardiometabolic and gastrointestinal health: the WellFed randomised controlled trial
The early postpartum period is a time of intense metabolic and physiological stress as maternal recovery from pregnancy impacts immune, cardiometabolic and gastrointestinal health. Studies considering the effect of nutrition on key maternal health parameters at this critical period are lacking. A combined supplement of bovine casein hydrolysate and yeast β-glucan has been shown to improve growth, intestinal health and inflammation in animal models, but studies in humans, including early postpartum lactating women, are lacking. In this 4-week randomised controlled trial, breastfeeding women ( n 58) at 4-weeks postpartum consumed a supplement containing either: 1) a combination of 250 mg casein hydrolysate (LFC16) and 250 mg yeast β-glucan (Wellmune®) or 2) a maltodextrin control. Gastrointestinal health was self-assessed using the Structured Assessment of Gastro-Intestinal Symptoms (SAGIS) tool. At baseline, mothers reported an issue with constipation (56.5%), difficulty with defaecation (58.7%), an urgency to defaecate (6.7%), or diarrhoea (6.7%). In response to intervention, cytokine expression in peripheral blood mononuclear cells (PBMCs) and cardiometabolic health were unchanged following supplementation. After 4-weeks the intervention improved constipation domain scores ( P = 0.049) and was almost twice as likely to improve SAGIS total domain score (80.0%) compared to control (45.5%, P = 0.011). This work highlights the residual effects of pregnancy on maternal gastrointestinal health parameters in the early postpartum period, and the potential of a combined casein hydrolysate and yeast β-glucan to improve gastrointestinal health, although limited findings on inflammation were observed. Further studies in larger sample sizes are warranted.
- Open Access
- 28 August 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e89207
Improving Proactive Primary Health Care After Gestational Diabetes: Protocol for Implementation and Evaluation of a Quality Improvement Collaborative Program in General Practice (GooD4Mum) and Baseline Practice Characteristics
Background: Gestational diabetes mellitus (GDM) is increasingly common, with short- and long-term health risks. Building on the GooD4Mum pilot, which demonstrated quality improvements in general practice for care after GDM, this project implemented and evaluated a primary care Quality Improvement Collaborative (QIC) program to optimize identification, recall, screening, and referral of patients after GDM. Objective: This study aimed to assess the effectiveness of QIC activities relative to usual practice for improving general practice clinicians’ provision of follow-up and screening of patients with a history of GDM to ultimately support the onset of type 2 diabetes. Methods: A 21-month, prospective non–randomized controlled trial (at practice level) was conducted, matching intervention practices 1:1 with controls. The QIC intervention is compared with care-as-usual in general practice to review implementation, effectiveness, and economic outcomes. For 18 months, the intervention practices engaged with the GooD4Mum QIC program, including education, training, resources, and Plan-Do-Study-Act (PDSA) cycles to implement locally relevant improvement activities. A clinical decision support system aided in the identification, screening, and tracking of patients with a history of GDM. Control practices provided care as usual. Primary outcomes are practice-level proportions of women with recorded type 2 diabetes screening, modifiable cardiometabolic risk factors, and referral to a diabetes prevention program. Secondary outcomes examine changes in care processes, adherence to clinical standards, and fidelity of intervention delivery. Outcome analyses use clinical data derived from practices via automated extraction. Baseline comparisons use t tests or chi-square tests. Primary and secondary outcomes are analyzed by repeated-measures ANOVA and/or cluster-adjusted generalized estimating equations, accounting for practice-level clustering, and sensitivity analyses include a per-protocol approach. Implementation outcomes are assessed through longitudinal qualitative interviews with practice leads, support staff, and stakeholders, guided by the CFIR (Consolidated Framework for Implementation Research) and the RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance) framework. Cost consequence analysis uses clinical activity and practice-reported data. Results: The program ran in 9 general practices between April 2024 and September 2025, with data collection until December 2025. Practice characteristics and protocol deviation are summarized. Detailed outcome, cost consequence, and implementation process evaluations will be reported elsewhere. Conclusions: The protocol offers a novel quality improvement approach enhanced by clinical decision support and automated data extraction to optimize identification, screening, and provision of lifestyle advice toward reducing type 2 diabetes after GDM. The evaluation is designed to generate actionable insights and a scalable implementation toolkit to improve care after gestational diabetes.
- 28 August 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e89207
Open AccessImproving Proactive Primary Health Care After Gestational Diabetes: Protocol for Implementation and Evaluation of a Quality Improvement Collaborative Program in General Practice (GooD4Mum) and Baseline Practice Characteristics
Background: Gestational diabetes mellitus (GDM) is increasingly common, with short- and long-term health risks. Building on the GooD4Mum pilot, which demonstrated quality improvements in general practice for care after GDM, this project implemented and evaluated a primary care Quality Improvement Collaborative (QIC) program to optimize identification, recall, screening, and referral of patients after GDM. Objective: This study aimed to assess the effectiveness of QIC activities relative to usual practice for improving general practice clinicians’ provision of follow-up and screening of patients with a history of GDM to ultimately support the onset of type 2 diabetes. Methods: A 21-month, prospective non–randomized controlled trial (at practice level) was conducted, matching intervention practices 1:1 with controls. The QIC intervention is compared with care-as-usual in general practice to review implementation, effectiveness, and economic outcomes. For 18 months, the intervention practices engaged with the GooD4Mum QIC program, including education, training, resources, and Plan-Do-Study-Act (PDSA) cycles to implement locally relevant improvement activities. A clinical decision support system aided in the identification, screening, and tracking of patients with a history of GDM. Control practices provided care as usual. Primary outcomes are practice-level proportions of women with recorded type 2 diabetes screening, modifiable cardiometabolic risk factors, and referral to a diabetes prevention program. Secondary outcomes examine changes in care processes, adherence to clinical standards, and fidelity of intervention delivery. Outcome analyses use clinical data derived from practices via automated extraction. Baseline comparisons use t tests or chi-square tests. Primary and secondary outcomes are analyzed by repeated-measures ANOVA and/or cluster-adjusted generalized estimating equations, accounting for practice-level clustering, and sensitivity analyses include a per-protocol approach. Implementation outcomes are assessed through longitudinal qualitative interviews with practice leads, support staff, and stakeholders, guided by the CFIR (Consolidated Framework for Implementation Research) and the RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance) framework. Cost consequence analysis uses clinical activity and practice-reported data. Results: The program ran in 9 general practices between April 2024 and September 2025, with data collection until December 2025. Practice characteristics and protocol deviation are summarized. Detailed outcome, cost consequence, and implementation process evaluations will be reported elsewhere. Conclusions: The protocol offers a novel quality improvement approach enhanced by clinical decision support and automated data extraction to optimize identification, screening, and provision of lifestyle advice toward reducing type 2 diabetes after GDM. The evaluation is designed to generate actionable insights and a scalable implementation toolkit to improve care after gestational diabetes.
- Open Access
- 22 July 2026
- Published by Oxford University Press (OUP) in Nutrition Reviews
Health Economics of Primary Care Nutrition Interventions: a Systematic Review and Meta-Analysis
Context: Non communicable diseases (NCDs) impose a major global health and economic burden, with poor diet recognized as a leading modifiable risk factor. Nutrition interventions delivered by qualified professionals in primary care settings are recommended for prevention and management of NCDs, yet their economic value remains uncertain. Objective: We sought to systematically review and synthesize evidence on the cost-effectiveness of nutrition care interventions delivered by nutrition professionals in primary care, from both societal and health care system perspectives. Data Sources: A comprehensive search of 6 databases (Ovid Medline, PubMed, Embase, CINAHL, Cochrane CENTRAL, EconLit) was conducted up to October 2024 following Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines (Supporting Materials). The protocol was registered in PROSPERO under the number: CRD420251029435. Data Extraction: Randomized controlled trials reporting economic evaluations of primary care nutrition interventions were eligible. Two reviewers independently screened studies and extracted data on intervention characteristics, cost perspective, incremental costs, incremental effects, and quality-adjusted life years. Risk of bias was assessed using the Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) checklist. Data Analysis: The incremental net benefit (INB) was calculated using harmonized cost and effect data. The meta-analysis employed random-effects models stratified by perspective. Sensitivity analyses excluded influential outliers. Subgroup analyses explored variations by delivery mode, target condition, and study quality. Conclusions: Among 25 included studies, 56% were cost-effective and 20% were moderately cost-effective. Pooled INB favored cost-effectiveness from a societal perspective (€650.32), while the health care system perspective indicated initial investment requirements (−€402.65). Telehealth delivery and diabetes-focused interventions demonstrated the strongest economic outcomes. Despite high heterogeneity, sensitivity analyses improved pooled estimates, reinforcing the robustness of findings. Nutrition interventions in primary care represent a strategic opportunity to improve health outcomes and optimize resource allocation, particularly when integrated into telehealth models and multidisciplinary care frameworks. Systematic Review Registration: PROSPERO registration No. [CRD420251029435].
- 22 July 2026
- Published by Oxford University Press (OUP) in Nutrition Reviews
Open AccessHealth Economics of Primary Care Nutrition Interventions: a Systematic Review and Meta-Analysis
Context: Non communicable diseases (NCDs) impose a major global health and economic burden, with poor diet recognized as a leading modifiable risk factor. Nutrition interventions delivered by qualified professionals in primary care settings are recommended for prevention and management of NCDs, yet their economic value remains uncertain. Objective: We sought to systematically review and synthesize evidence on the cost-effectiveness of nutrition care interventions delivered by nutrition professionals in primary care, from both societal and health care system perspectives. Data Sources: A comprehensive search of 6 databases (Ovid Medline, PubMed, Embase, CINAHL, Cochrane CENTRAL, EconLit) was conducted up to October 2024 following Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines (Supporting Materials). The protocol was registered in PROSPERO under the number: CRD420251029435. Data Extraction: Randomized controlled trials reporting economic evaluations of primary care nutrition interventions were eligible. Two reviewers independently screened studies and extracted data on intervention characteristics, cost perspective, incremental costs, incremental effects, and quality-adjusted life years. Risk of bias was assessed using the Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) checklist. Data Analysis: The incremental net benefit (INB) was calculated using harmonized cost and effect data. The meta-analysis employed random-effects models stratified by perspective. Sensitivity analyses excluded influential outliers. Subgroup analyses explored variations by delivery mode, target condition, and study quality. Conclusions: Among 25 included studies, 56% were cost-effective and 20% were moderately cost-effective. Pooled INB favored cost-effectiveness from a societal perspective (€650.32), while the health care system perspective indicated initial investment requirements (−€402.65). Telehealth delivery and diabetes-focused interventions demonstrated the strongest economic outcomes. Despite high heterogeneity, sensitivity analyses improved pooled estimates, reinforcing the robustness of findings. Nutrition interventions in primary care represent a strategic opportunity to improve health outcomes and optimize resource allocation, particularly when integrated into telehealth models and multidisciplinary care frameworks. Systematic Review Registration: PROSPERO registration No. [CRD420251029435].
- Open Access
- 12 May 2026
- Published by Wiley in Diabetic Medicine
- Vol. 43 (7) , e70361
Understanding interconception experiences of women with previous gestational diabetes mellitus across Ireland
Aim: To explore the interconception experiences of women after GDM across Ireland to inform how to optimise health between pregnancies. Methods: A qualitative descriptive study was implemented. Online semi‐structured individual interviews were conducted (April–May 2025) with women living on the island of Ireland who had experienced GDM ≤5 years ago. Data were transcribed and analysed inductively using reflexive thematic analysis. Results: Twenty‐seven women participated, and four themes were generated: (1) Shaping health behaviours beyond pregnancy, (2) GDM's emotional legacy, (3) Understanding interconception care and future risk management and (4) Interconception needs and support preferences. Conclusions: This study provides novel insights into women's interconception experiences following GDM across Ireland and shows behavioural, emotional and healthcare‐related impacts between pregnancies. Although education received during pregnancy facilitated behaviour change that persisted postpartum, maintaining GDM‐related positive health behaviour changes was often challenging without ongoing support. Postpartum care gaps and a lack of interconception support left women uncertain about their future GDM risk and appropriate pregnancy preparation. These findings highlight the need for interconception care including timely postpartum follow‐up, clearer communication about recurrence risk and accessible preconception support for women planning a subsequent pregnancy.
- 12 May 2026
- Published by Wiley in Diabetic Medicine
- Vol. 43 (7) , e70361
Open AccessUnderstanding interconception experiences of women with previous gestational diabetes mellitus across Ireland
Aim: To explore the interconception experiences of women after GDM across Ireland to inform how to optimise health between pregnancies. Methods: A qualitative descriptive study was implemented. Online semi‐structured individual interviews were conducted (April–May 2025) with women living on the island of Ireland who had experienced GDM ≤5 years ago. Data were transcribed and analysed inductively using reflexive thematic analysis. Results: Twenty‐seven women participated, and four themes were generated: (1) Shaping health behaviours beyond pregnancy, (2) GDM's emotional legacy, (3) Understanding interconception care and future risk management and (4) Interconception needs and support preferences. Conclusions: This study provides novel insights into women's interconception experiences following GDM across Ireland and shows behavioural, emotional and healthcare‐related impacts between pregnancies. Although education received during pregnancy facilitated behaviour change that persisted postpartum, maintaining GDM‐related positive health behaviour changes was often challenging without ongoing support. Postpartum care gaps and a lack of interconception support left women uncertain about their future GDM risk and appropriate pregnancy preparation. These findings highlight the need for interconception care including timely postpartum follow‐up, clearer communication about recurrence risk and accessible preconception support for women planning a subsequent pregnancy.
- Open Access
- 22 April 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Designing and implementing a prediabetes screening in community pharmacies and online prevention program: findings from the PREDICT study
Diabetes is a major public health challenge, driving increased morbidity and healthcare costs. Early detection of prediabetes is essential to halt or rever
- 22 April 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Open AccessDesigning and implementing a prediabetes screening in community pharmacies and online prevention program: findings from the PREDICT study
Diabetes is a major public health challenge, driving increased morbidity and healthcare costs. Early detection of prediabetes is essential to halt or rever
- Open Access
Breastfeeding and later depression and anxiety in mothers in Ireland: a 10-year prospective observational study
Objectives: Although breastfeeding is associated with lower postnatal depression and anxiety, limited research exists regarding long-term maternal mental health outcomes. This study examined the association between breastfeeding and depression and anxiety in women of later reproductive age (mid 30s to menopause). Design: This was a 10-year prospective longitudinal cohort study. Self-reported questionnaires were used to collect lifetime breastfeeding behaviour at 10 years, and health history including depression, anxiety and medication use was collected at each study timepoint. Setting: A tertiary level maternity hospital in Dublin, Ireland. Participants: 168 parous women from the ROLO Longitudinal Cohort with lifetime breastfeeding behaviour and health history data available at 10 years were included (22% of total cohort). Women currently pregnant or breastfeeding at 10-year follow-up were excluded. Results: Mean (SD) age at study end was 42.4 (3.8) years. 72.6% (n=122) of women reported ever breastfeeding. Median lifetime exclusive breastfeeding was 5.5 weeks (IQR 35.8, range 0–190). 37.5% of women (n=63) breastfed for ≥12 months over their lifetime. 13.1% (n=22) reported depression or anxiety at 10 years, and 20.8% (n=35) reported depression or anxiety over the whole study period. Ever breastfeeding was associated with less depression and anxiety at 10 years (OR 0.34, 95% CI 0.12 to 0.94, p=0.04). Ever breastfeeding, longer exclusive breastfeeding and lifetime breastfeeding ≥12 months were associated with lower depression and anxiety over the whole study period (ever breastfeeding OR 0.4, p=0.03; exclusive breastfeeding OR 0.98/week, p=0.03; lifetime breastfeeding ≥12 months OR 0.38, p=0.04). Conclusion: There may be a protective association between breastfeeding and self-reported depression and anxiety. Further studies are required to confirm the findings. Trial registration number: ISRCTN54392969 .
Open AccessBreastfeeding and later depression and anxiety in mothers in Ireland: a 10-year prospective observational study
Objectives: Although breastfeeding is associated with lower postnatal depression and anxiety, limited research exists regarding long-term maternal mental health outcomes. This study examined the association between breastfeeding and depression and anxiety in women of later reproductive age (mid 30s to menopause). Design: This was a 10-year prospective longitudinal cohort study. Self-reported questionnaires were used to collect lifetime breastfeeding behaviour at 10 years, and health history including depression, anxiety and medication use was collected at each study timepoint. Setting: A tertiary level maternity hospital in Dublin, Ireland. Participants: 168 parous women from the ROLO Longitudinal Cohort with lifetime breastfeeding behaviour and health history data available at 10 years were included (22% of total cohort). Women currently pregnant or breastfeeding at 10-year follow-up were excluded. Results: Mean (SD) age at study end was 42.4 (3.8) years. 72.6% (n=122) of women reported ever breastfeeding. Median lifetime exclusive breastfeeding was 5.5 weeks (IQR 35.8, range 0–190). 37.5% of women (n=63) breastfed for ≥12 months over their lifetime. 13.1% (n=22) reported depression or anxiety at 10 years, and 20.8% (n=35) reported depression or anxiety over the whole study period. Ever breastfeeding was associated with less depression and anxiety at 10 years (OR 0.34, 95% CI 0.12 to 0.94, p=0.04). Ever breastfeeding, longer exclusive breastfeeding and lifetime breastfeeding ≥12 months were associated with lower depression and anxiety over the whole study period (ever breastfeeding OR 0.4, p=0.03; exclusive breastfeeding OR 0.98/week, p=0.03; lifetime breastfeeding ≥12 months OR 0.38, p=0.04). Conclusion: There may be a protective association between breastfeeding and self-reported depression and anxiety. Further studies are required to confirm the findings. Trial registration number: ISRCTN54392969 .
- Open Access
- 22 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Improving proactive primary healthcare after gestational diabetes: Protocol for evaluation of a quality improvement collaborative program in general practice (GooD4Mum) (Preprint)
BACKGROUND Gestational diabetes mellitus (GDM) is increasingly common with short and long-term health risks. The GooD4Mum pilot demonstrated quality improvements in general practice for care of patients after GDM. Building on the pilot, this project aimed to optimise provision of care by implementing and evaluating a program targeting identification, recall, screening and referral of patients after GDM within routine general practice. OBJECTIVE The study was designed to assess the effectiveness of Quality Improvement Collaborative (QIC) activities relative to usual practice for improving general practice clinicians’ provision of follow up and screening of patients with a history of gestational diabetes, to ultimately support prevention of onset of type 2 diabetes. METHODS A 21-month, prospective non-randomised controlled trial in primary care that compared a quality improvement collaborative (QIC) intervention to care-as-usual at the practice level, to review practice-level implementation, effectiveness and economic outcomes. Nine intervention practices were recruited and matched 1:1 with controls. For 18-months, the intervention practices engaged with the GooD4Mum QIC initiative including education, training, resources and quality improvement, using Plan-Do-Study-Act cycles. Control practices provided care as usual. A clinical decision support system aided identification, screening and tracking of patients with history of GDM. Intervention practices determined and established suitable improvement activities. Quantitative and qualitative data will be utilised, including quantitative data derived from practices periodically via automated data extraction. Implementation outcomes will be assessed through longitudinal qualitative interviews with practice leads, support staff and other stakeholders, guided by the Consolidated Framework for Implementation Research (CFIR) and the RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance) framework. RESULTS The program ran in general practices between April 2024 and September 2025 with data collection continuing until the end of December 2025. Primary outcomes are the proportions of women with history of GDM in intervention and control practices who have recorded: type 2 diabetes mellitus (T2DM)-screening, modifiable cardiometabolic risk factors, referral to a diabetes prevention program. Secondary outcomes focus on professional practice improvement assessed via changes in processes of care, adherence to clinical standards and fidelity of intervention delivery. Detailed implementation process and economic evaluations will be conducted. CONCLUSIONS The program proposes a novel quality improvement approach in primary care to optimise identification, screening and provision of lifestyle advice toward reducing onset of T2DM after GDM. Insights into primary care quality improvement processes and strategies to improve post GRM care are anticipated. CLINICALTRIAL On consultation with the University of Melbourne trials unit, this study did not meet the WHO/ICMJE 2008 definition of a clinical trial which prospectively assigns human participants to health-related interventions to evaluate the effects on health outcomes, so was not registered. This study focuses on influencing clinician knowledge and activity. Evaluating effects of the program on patient education or health outcomes was beyond the scope of the study.
- 22 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImproving proactive primary healthcare after gestational diabetes: Protocol for evaluation of a quality improvement collaborative program in general practice (GooD4Mum) (Preprint)
BACKGROUND Gestational diabetes mellitus (GDM) is increasingly common with short and long-term health risks. The GooD4Mum pilot demonstrated quality improvements in general practice for care of patients after GDM. Building on the pilot, this project aimed to optimise provision of care by implementing and evaluating a program targeting identification, recall, screening and referral of patients after GDM within routine general practice. OBJECTIVE The study was designed to assess the effectiveness of Quality Improvement Collaborative (QIC) activities relative to usual practice for improving general practice clinicians’ provision of follow up and screening of patients with a history of gestational diabetes, to ultimately support prevention of onset of type 2 diabetes. METHODS A 21-month, prospective non-randomised controlled trial in primary care that compared a quality improvement collaborative (QIC) intervention to care-as-usual at the practice level, to review practice-level implementation, effectiveness and economic outcomes. Nine intervention practices were recruited and matched 1:1 with controls. For 18-months, the intervention practices engaged with the GooD4Mum QIC initiative including education, training, resources and quality improvement, using Plan-Do-Study-Act cycles. Control practices provided care as usual. A clinical decision support system aided identification, screening and tracking of patients with history of GDM. Intervention practices determined and established suitable improvement activities. Quantitative and qualitative data will be utilised, including quantitative data derived from practices periodically via automated data extraction. Implementation outcomes will be assessed through longitudinal qualitative interviews with practice leads, support staff and other stakeholders, guided by the Consolidated Framework for Implementation Research (CFIR) and the RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance) framework. RESULTS The program ran in general practices between April 2024 and September 2025 with data collection continuing until the end of December 2025. Primary outcomes are the proportions of women with history of GDM in intervention and control practices who have recorded: type 2 diabetes mellitus (T2DM)-screening, modifiable cardiometabolic risk factors, referral to a diabetes prevention program. Secondary outcomes focus on professional practice improvement assessed via changes in processes of care, adherence to clinical standards and fidelity of intervention delivery. Detailed implementation process and economic evaluations will be conducted. CONCLUSIONS The program proposes a novel quality improvement approach in primary care to optimise identification, screening and provision of lifestyle advice toward reducing onset of T2DM after GDM. Insights into primary care quality improvement processes and strategies to improve post GRM care are anticipated. CLINICALTRIAL On consultation with the University of Melbourne trials unit, this study did not meet the WHO/ICMJE 2008 definition of a clinical trial which prospectively assigns human participants to health-related interventions to evaluate the effects on health outcomes, so was not registered. This study focuses on influencing clinician knowledge and activity. Evaluating effects of the program on patient education or health outcomes was beyond the scope of the study.